Combination tablets integrating alpha-blocker and 5-alpha reductase inhibitor for urological applications in benign prostatic hyperplasia management. Utilized by hospitals, clinics, and pharmacies; manufactured by pharmaceutical firms and supplied via wholesalers to healthcare procurement teams and distributors.